Our main positive piece of news is quite recent: a very well known US investment bank has chosen our software tools to run their new exotic and structured product equity business.
We take it as a vote of confidence that our approach of "small, niche, and high quality" can deliver better solutions than much larger competition - even when they offer huge discounts.
We are directing the sale of pure software tools to similar customers, while focusing on fuller "services" for the others e.g. buy-side.
In particular, we have re-focused our offering on structured products around our strengths, see here.
As part of that, the less positive news. In the summer we finally decided to stop selling our software to Catley-Lakeman, one of our historic customers, as the economics did not work anymore for either of us. This was consensual, and we wish them every success.
Finally, we continue to be closely involved with partners and customers in the OTC derivatives markets, and are in discussions on how to increase synergies there.
Over the year we have released major new features and improvements, frankly too many to list here.
I'll just mention vastly improved databases, the new SP-Investor analysis tool, richer and even more flexible scenarios and stresses, improved global modelling of the volsurface, ... let's stop here before it gets too boring.
Merry XMas, and best wishes for the new year.